|
Device | DIASORIN ETI-MAK-2 PLUS ASSAY |
Generic Name | Test, hepatitis b (b core, be antigen, be antibody, b core igm) |
Applicant | DIASORIN, INC. 1951 NORTHWESTERN AVE. STILLWATER, MN 55082-0285 |
PMA Number | P990038 |
Supplement Number | S005 |
Date Received | 07/16/2003 |
Decision Date | 08/20/2003 |
Withdrawal Date
|
10/10/2023 |
Product Code |
LOM |
Advisory Committee |
Microbiology |
Supplement Type | Special (Immediate Track) |
Supplement Reason | Labeling Change - Indications/instructions/shelf life/tradename |
Expedited Review Granted? | No |
Combination Product | No |
Approval Order Statement APPROVAL FOR A REVISION IN THE ASSAY PACKAGE INSERT THAT INCORPORATES A CHANGE IN THE INTERPRETATION ALGORITHM FOR REPEAT TESTING RESULTS THAT MAKE IT THE SAME AS THE INTERPRETATION FOR INITIAL TESTING. "THE USER SHOULD APPLY THE SAME INTERPRETATION OF RESULTS (I.E. REACTIVE SAMPLES SHOULD HAVE AN ABSORBANCE VALUE GREATER THAN 90% OF THE CUTOFF) WHEN INITIAL TESTING FOR SOME SAMPLES AND REPEAT TESTING FOR OTHER SAMPLES ARE PERFORMED ON THE SAME PLATE." |